What's breaking now, across thousands of outlets.
J&J’s Imaavy wins label expansion: The monoclonal antibody is now the first treatment approved specifically for warm autoimmune hemolytic anemia, a rare autoantibody disease that causes severe anemia and fatigue. Imaavy ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
TEVIMBRA plus ZIIHERA and chemotherapy is the first and only immunotherapy-based regimen to deliver more than two years of median OS in first-line HER2+ GEA, regardless of PD-L1 status Regimen poised…
(MedPage Today) -- Florida chef Elijah Button was chopping onions in June when his knife slipped and sliced his middle finger to the bone. It was his worst kitchen accident to date.
Bladder cancer claims 220,000 lives globally each year, with symptoms sometimes mistaken for other conditions such as kidney stones.
ICE's fentanyl work plummeted as immigration enforcement surged under Trump's mass deportation push, the DHS watchdog said.
